ABSTRACT
Nutraceuticals are the food elements that have demonstrated therapeutic as well as health benefitting profiles (Srividya et al., 2010). During the past few years, researchers have established the fact that nutraceuticals are endowed with properties that can shield against a number of diseases, along with perking up our lifestyle (Shahidi, 2012). However, the challenges including low bioavailability and faster removal from body are also associated with them, leading to their partial assimilation, ensuing weakened or no biological effect (Acosta, 2009; Nair et al., 2010). New and emerging technologies, like nanotechnology, have the potential to redesign these natural elements for their efficient delivery with the aim to enhance their biological activity (Lopes et al., 2013). A vast range of delivery systems have been produced to encapsulate and target the control release of various bioactive compounds and enhance the bioavailability as well as clinical efficacy of nutraceuticals (Singh, 2016). Nanoparticles-delivered nutraceuticals have fascinated researchers across the globe due to their superior anticancer prospective and promising role in clinics (Men et al., 2014). This chapter will discuss the applications of nanotechnology in nutraceutical delivery for cancer therapy.
